Category: St. Jude MedicalSyndicate content

St. Jude Medical wins FDA approval for Ilumien Optis device

October 22, 2013 by Brad Perriello

St. Jude Medical says the FDA approved its Ilumien Optis device, designed to measure blood flow and provide images of the heart during stenting procedures.

St. Jude Medical wins FDA approval for Ilumien Optis device

St. Jude Medical (NYSE:STJ) said today that the FDA granted pre-market approval for its next-generation Ilumien Optis device, which combines a pair of technologies to help guide physicians during stenting procedures.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

St. Jude Medical seeks to toss shareholders class action

October 17, 2013 by Brad Perriello

St. Jude Medical wants a federal judge in Minnesota to toss a shareholders class action lawsuit filed against the medical device company and its management.

St. Jude Medical seeks to toss shareholders class action

St. Jude Medical (NYSE:STJ) wants a federal judge in Minnesota to toss a class action lawsuit filed by shareholders after the medical device company's stock took a dive in 2009 when it reduced its guidance.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

FDA issues tissue erosion warning on St. Jude's Amplatzer cardiac implant

October 17, 2013 by Arezu Sarvestani

The FDA warns that, in rare cases, St. Jude Medical's Amplatzer atrial septal occluder may erode tissue in the heart, creating holes that require open-heart surgery to mend.

Updated October 17, 2013, at 5 p.m.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

St. Jude Medical gains on Q3 beat, enhanced outlook

October 16, 2013 by Brad Perriello

Shares of St. Jude Medical gain in early-morning trading after the medical device company beats Wall Street's sales and earnings expectations and increases its outlook for the rest of the year.

St. Jude Medical gains on Q3 beat, enhanced outlook

St. Jude Medical (NYSE:STJ) shares gained in early-morning trading today after the medical device company said it beat Wall Street's expectations for sales and earnings and boosted its outlook for the rest of 2013.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

St. Jude Medical jumps on Nanostim buyout

October 15, 2013 by Brad Perriello

Shares of St. Jude Medical jump on news of its buyout of Nanostim following European approval of its leadless pacemaker.

St. Jude Medical jumps on Nanostim buyout

St. Jude Medical (NYSE:STJ) shares gained 1.6% after the medical device company said it acquired Nanostim and its miniature leadless pacemaker following European approval of the device.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

St. Jude CEO Starks snarks rivals' 'lack of imagination'

October 11, 2013 by Arezu Sarvestani

St. Jude CEO Daniel Starks says his rivals' laser-focus on cheaper medical devices for emerging markets puts too much stake in the present rather than looking to the future.

St. Jude CEO Starks snarks rivals

St. Jude Medical (NYSE:STJ) CEO Daniel Starks has his own key to success, and it doesn't jibe well with some of his rivals, who he left unnamed in his criticism.

St. Jude CEO Starks' recipe for innovation | MassDevice.com On Call

October 11, 2013 by Arezu Sarvestani

The keys to a huge payoff in the medical device industry are cost-cutting technologies and those that target the right disease states, according to St. Jude CEO Daniel Starks.

MassDevice On Call

MASSDEVICE ON CALL — The medical device industry has some pretty big hurdles to face, but companies can still land big wins if they can hit the market's "sweet spot", according to St. Jude Medical (NYSE:STJ) CEO Daniel Starks.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp